AC Immune (ACIU) Change in Accured Expenses (2015 - 2025)

AC Immune (ACIU) has 11 years of Change in Accured Expenses data on file, last reported at -$4.7 million in Q4 2025.

• On a quarterly basis, Change in Accured Expenses fell 328.95% year-over-year to -$4.7 million in Q4 2025; TTM through Dec 2025 was -$4.7 million, a 407.74% decrease from a year earlier, with the FY2025 full-year figure at -$4.7 million, down 397.12% from the prior year.
• Change in Accured Expenses for Q4 2025 stood at -$4.7 million, down from $645056.5 in the prior quarter.
• Over the last five years, Change in Accured Expenses for ACIU reached as high as $3.3 million in Q4 2021 and fell as low as -$5.6 million in Q1 2022.
• Historically, Change in Accured Expenses has averaged -$55722.4 across 5 years, with a median of $399811.7 in 2025.
• Across the five-year window, Change in Accured Expenses surged 4222.27% in 2021 and tumbled 3746.87% in 2025, its largest moves.
• Year by year, Change in Accured Expenses stood at $3.3 million in 2021, then sank by 83.23% to $561217.5 in 2022, then jumped by 148.08% to $1.4 million in 2023, then slumped by 178.71% to -$1.1 million in 2024, then tumbled by 328.95% to -$4.7 million in 2025.
• Per Business Quant data, the three most recent Change in Accured Expenses figures were -$4.7 million in Q4 2025, $645056.5 in Q3 2025, and $399811.7 in Q2 2025.